A detailed history of Gamma Investing LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 518 shares of ITCI stock, worth $44,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares
518
Previous 401 29.18%
Holding current value
$44,387
Previous $27.5 Million 38.01%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$67.99 - $80.84 $7,954 - $9,458
117 Added 29.18%
518 $37.9 Million
Q2 2024

Jul 02, 2024

BUY
$64.76 - $79.84 $6,735 - $8,303
104 Added 35.02%
401 $27.5 Million
Q1 2024

Apr 05, 2024

BUY
$64.37 - $75.65 $2,703 - $3,177
42 Added 16.47%
297 $20.6 Million
Q4 2023

Feb 01, 2024

BUY
$46.37 - $73.65 $11,824 - $18,780
255 New
255 $17.2 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.09B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.